| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |